EPS for Marten Transport, Ltd. (MRTN) Expected At $0.25; Mednax (MD) SI Decreased By 0.84%


Analysts expect Marten Transport, Ltd. (NASDAQ:MRTN) to report $0.25 EPS on April, 18.They anticipate $0.06 EPS change or 31.58% from last quarter’s $0.19 EPS. MRTN’s profit would be $13.62 million giving it 17.91 P/E if the $0.25 EPS is correct. After having $0.29 EPS previously, Marten Transport, Ltd.’s analysts see -13.79% EPS growth. The stock decreased 1.00% or $0.18 during the last trading session, reaching $17.91. About 298,998 shares traded or 21.97% up from the average. Marten Transport, Ltd. (NASDAQ:MRTN) has declined 15.74% since March 17, 2018 and is downtrending. It has underperformed by 20.11% the S&P500. Some Historical MRTN News: 19/04/2018 – Marten Transport 1Q Net $10.3M; 27/03/2018 – Marten Transport Closes Below 50-Day Moving Average: Technicals; 07/03/2018 Marten Transport Declares Quarterly Dividend; 19/04/2018 – Marten Transport 1Q EPS 19c; 21/04/2018 – DJ Marten Transport Ltd, Inst Holders, 1Q 2018 (MRTN); 19/04/2018 – MARTEN TRANSPORT 1Q EPS 19C, EST. 19C; 19/04/2018 – Marten Transport 1Q Rev $187M; 19/04/2018 – MARTEN TRANSPORT 1Q OPER REV. $187.0M, EST. $188.5M; 07/03/2018 – Marten Transport Declares Dividend of 2.5c

Mednax Inc (NYSE:MD) had a decrease of 0.84% in short interest. MD’s SI was 2.90 million shares in March as released by FINRA. Its down 0.84% from 2.93 million shares previously. With 1.37M avg volume, 2 days are for Mednax Inc (NYSE:MD)’s short sellers to cover MD’s short positions. The SI to Mednax Inc’s float is 3.38%. The stock decreased 1.86% or $0.57 during the last trading session, reaching $30.04. About 1.44M shares traded or 23.58% up from the average. MEDNAX, Inc. (NYSE:MD) has declined 39.48% since March 17, 2018 and is downtrending. It has underperformed by 43.85% the S&P500. Some Historical MD News: 26/04/2018 – Mednax process on life support; 27/03/2018 – MEDNAX INC MD.N : CREDIT SUISSE STARTS WITH NEUTRAL; TARGET PRICE $57; 08/03/2018 – HELLMAN & FRIEDMAN IS ALSO SAID TO MAKE INDICATIVE MEDNAX BID; 01/05/2018 – MEDNAX EXECUTIVE MAKES COMMENT ON EARNINGS CONFERENCE CALL; 30/04/2018 – MEDNAX SEES 2Q ADJ EPS $1.04 TO $1.09, EST. $1.07; 07/05/2018 – ATRIUM REITERATES WON’T NEGOTIATE NEW PACT WITH MEDNAX; 30/04/2018 – Mednax 1Q Net $63.4M; 02/04/2018 – MEDNAX INC – WITH ACQUISITION, FOUR PHYSICIAN GROUP PRACTICES HAVE BECOME PART OF MEDNAX IN 2018; 08/03/2018 – Former HHS Secretary Donna Shalala Steps Down From Mednax Board in Connection With Bid for U.S. House Seat in Florida; 26/04/2018 – Mednax process on life support, sources say [20:30 BST26 Apr 2018] [Proprietary] []

Among 8 analysts covering Mednax (NYSE:MD), 3 have Buy rating, 1 Sell and 4 Hold. Therefore 38% are positive. Mednax had 12 analyst reports since September 18, 2018 according to SRatingsIntel. The rating was maintained by Robert W. Baird on Friday, November 2 with “Neutral”. Robert W. Baird maintained MEDNAX, Inc. (NYSE:MD) on Friday, October 19 with “Neutral” rating. The firm earned “Outperform” rating on Tuesday, November 6 by Credit Suisse. The stock has “Outperform” rating by Leerink Swann on Monday, September 24. The firm has “Outperform” rating by Credit Suisse given on Wednesday, February 13. The stock of MEDNAX, Inc. (NYSE:MD) earned “Neutral” rating by Bank of America on Tuesday, September 18. On Monday, February 25 the stock rating was maintained by UBS with “Sell”. BMO Capital Markets maintained it with “Market Perform” rating and $43 target in Friday, November 2 report. The company was upgraded on Tuesday, January 15 by Citigroup.

MEDNAX, Inc., together with its subsidiaries, provides neonatal, anesthesia, maternal-fetal, and other pediatric subspecialties physician services in the United States and Puerto Rico. The company has market cap of $2.60 billion. The firm offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; anesthesia and anesthesia subspecialty care; and acute and chronic pain management services. It has a 10.25 P/E ratio. It also provides maternal-fetal care, including inpatient and office clinical care to expectant mothers and their unborn babies through maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians consisting of maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors.

More notable recent MEDNAX, Inc. (NYSE:MD) news were published by: Seekingalpha.com which released: “MEDNAX launches private $200M debt offering – Seeking Alpha” on February 19, 2019, also Benzinga.com with their article: “The Daily Biotech Pulse: Allergan’s Depression Drug Flunks Late-Stage Trial, Apellis Offering, ShockWave Medical IPO – Benzinga” published on March 07, 2019, Benzinga.com published: “Daily Biotech Pulse: Tonix Gets European Patent, EC Nod For Roche, Insys Earnings – Benzinga” on March 08, 2019. More interesting news about MEDNAX, Inc. (NYSE:MD) were released by: Globenewswire.com and their article: “Report: Exploring Fundamental Drivers Behind IHS Markit, Mednax, HFF, Scientific Games, El Pollo Loco, and Plexus — New Horizons, Emerging Trends, and Upcoming Developments – GlobeNewswire” published on February 26, 2019 as well as Businesswire.com‘s news article titled: “MEDNAX to Present at Upcoming Investor Conferences – Business Wire” with publication date: February 21, 2019.

Marten Transport, Ltd. operates as a temperature-sensitive truckload carrier for shippers in the United States, Canada, and Mexico. The company has market cap of $975.55 million. It operates through four divisions: Truckload, Dedicated, Intermodal, and Brokerage. It has a 17.91 P/E ratio. The Truckload segment transports food and other consumer packaged goods that require a temperature-controlled or insulated environment.

Since February 5, 2019, it had 0 insider buys, and 2 selling transactions for $1.90 million activity. $185,622 worth of Marten Transport, Ltd. (NASDAQ:MRTN) shares were sold by MARTEN RANDOLPH L.

Investors sentiment increased to 1.44 in 2018 Q4. Its up 0.26, from 1.18 in 2018Q3. It is positive, as 12 investors sold Marten Transport, Ltd. shares while 45 reduced holdings. 35 funds opened positions while 47 raised stakes. 37.41 million shares or 0.59% more from 37.19 million shares in 2018Q3 were reported. Parametric Ltd Co holds 0% in Marten Transport, Ltd. (NASDAQ:MRTN) or 132,647 shares. Barclays Public Limited Company stated it has 36,583 shares or 0% of all its holdings. Gotham Asset Mngmt Lc invested in 0.01% or 20,826 shares. Renaissance Limited Co holds 0% in Marten Transport, Ltd. (NASDAQ:MRTN) or 68,161 shares. Parkside Commercial Bank & holds 48 shares. Rmb Cap Management Limited Company has invested 0.01% of its portfolio in Marten Transport, Ltd. (NASDAQ:MRTN). Royal Bank & Trust Of Canada owns 320,416 shares. Bluemountain Cap Management Llc has 0.01% invested in Marten Transport, Ltd. (NASDAQ:MRTN) for 23,998 shares. Aqr Cap Mgmt Lc reported 96,529 shares or 0% of all its holdings. Cwm Ltd owns 505 shares. Hsbc Public Limited, United Kingdom-based fund reported 55,178 shares. 123,360 are owned by Oppenheimer Asset Management. Morgan Stanley reported 342,887 shares. Victory Mgmt Incorporated holds 2.09M shares. Prelude Mngmt Limited Com holds 434 shares.

MEDNAX, Inc. (NYSE:MD) Institutional Positions Chart